#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma recurrent Meningitis meningococcal Oesophageal squamous cell carcinoma Pneumonia Prolymphocytic leukaemia Congenital generalised lipodystrophy Propionic acidaemia Squamous cell carcinoma of the cervix Thrombocytosis Congenital hypotransferrinaemia Mucopolysaccharidosis II Vaginal cancer Autoimmune myositis Heart disease congenital Cerebral amyloid angiopathy More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome – Diagnostics Glycogen storage disease type II – Trials in Disease Glycogen storage disease type I – Basic Information Metachromatic leukodystrophy – Basic Information Mucous membrane pemphigoid – Trials in Disease Glycogen storage disease type V – Treatment Glomerulonephritis membranoproliferative – Life with Disease Factor VIII deficiency – Basic Information KBG syndrome – Diagnostics Rosai-Dorfman syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Prednisolone Acetate Ep0042 Eight Treg Ketamine Hydrochloride ASP3082 Lisaftoclax L-ARGININE MAGNESIUM CARBONATE HEAVY ALENDRONATE SODIUM TRIHYDRATE Sapablursen Falbikitug Aaa802 Afamelanotide Ginisortamab Cytisinicline Fluvastatin Sodium Lolium Perenne Pollen Extract Formoterol Fumarate Dihydrate Dupilumab Cetirizine More therapies…

    Learn about Your Condition

    Rasmussen encephalitis Eructation Pulmonary embolism Acute coronary syndrome Arterial disorder Endometrial cancer recurrent Oesophageal carcinoma Patent ductus arteriosus Cutaneous lupus erythematosus Ewing's sarcoma metastatic Adenosquamous cell lung cancer Vertebrobasilar stroke Hepatitis B Breast cancer in situ Glomerulonephritis acute More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Parc Tauli Hospital Universitari

Parc Tauli Hospital Universitari

Parc Del Tauli 1, Sabadell, 08208, Spain

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Alectinib and Durvalumab for Patients with Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Alectinib
    Belgium France Germany Italy The Netherlands Norway +3

  • Study on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren’s Syndrome

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Sjogren’s syndrome
    Investigated Drugs:
    • Hydroxychloroquine Sulfate
    • Leflunomide
    France Greece Italy The Netherlands Norway Spain +1

  • Study of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Bemarituzumab
    • Folinic Acid
    Belgium Bulgaria Czechia Denmark Estonia France +12

  • Study of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

    Not recruiting

    3 1 1
    Austria Belgium France Germany Italy The Netherlands +2

  • Long-term Study on Treatment Response in Chronic Hepatitis B Patients Using Bepirovirsen

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic hepatitis B
    Investigated Drugs:
    • Bepirovirsen
    Bulgaria France Germany Greece Hungary Italy +3

  • Study on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Austria France Germany Italy Poland Slovenia +2

  • Study on the Effectiveness of Apalutamide in Men with Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Apalutamide
    Austria Belgium Czechia Denmark France Germany +6

  • Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Ulcerative Colitis

    Not recruiting

    3 1
    Belgium Denmark France Italy Norway Poland +2

  • Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dostarlimab
    Spain

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Bulgaria Croatia Czechia Romania Slovakia Spain
Previous Page
1 … 17 18 19 20 21 … 29
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!